Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Challenges Begin to Impact NJ’s Life Sciences Market

5/6/2023

0 Comments

 
Trenton, NJ - National economic challenges and rising interest rates started to impact New Jersey’s life sciences market during the first quarter of 2023. During Q1, New Jersey posted an availability rate for lab/R&D space of 8.3%, an increase from the 7.4% the market posted in the fourth quarter of 2022. In fact, lab vacancy increased across the top 13 U.S. life sciences markets in the first quarter, providing relief for companies that had found little available space in recent years, according to a new report from CBRE.
“Despite obvious challenges ahead, the life sciences sector in New Jersey continues to perform incredibly well,” said Tom Sullivan, senior vice president at CBRE. “While we are seeing less venture capital, employment continues to be strong, as is demand for quality lab space.”
Given its status as the country’s fourth largest life sciences market, New Jersey is a major center for the pharmaceuticals and biotech businesses. There are currently six major tenants in the market seeking approximately 440,000 sq. ft. of Class A lab/R&D space, but only 400,000 sq. ft. available to meet demand. The 400,000 sq. ft. BeiGene biologic pharmaceutical manufacturing center is scheduled for completion in Q2 2023 and will serve as the firm’s flagship location. In addition, Infinity Biologix is expanding its Sampled SMART Labs facility in Piscataway, creating a state-of-the-art, 140,000-sq.-ft. lab and biorepository that will be one of the largest of its kind in the world when completed later this year. No other development is currently on the horizon.
Among the largest lease transactions in New Jersey during Q1 was Roche Molecular Systems’ 82,000-sq.-ft. renewal in Branchburg. The top sale transaction was Onyx/Machine Investment Group’s acquisition of 1.4 million sq. ft. in the Parkway North submarket and Ares Industrial RE Income Trust’s $7.7 million acquisition of a 50,000 sq. ft. facility in Princeton.
Nationally, lab vacancy increased across the top 13 U.S. life sciences markets in the first quarter, providing relief for companies that had found little available space in recent years. Average vacancy of 6.7% in the first quarter marked an increase of 170 basis points from a year earlier. That compares to an average of 7.7% in the first quarter of 2020, before the pandemic sparked a wave of activity in the life sciences sector. The low point for vacancy (4.6%) came during the second quarter of 2022.
Other measures differed in the first quarter, indicating a sector cooling to red hot from white hot. Despite announcements of layoffs, U.S. life sciences employment increased by 3.5% in February from a year earlier, exceeding the overall job-growth rate of 2.9%. Average rental rates increased by 3.2% from the fourth quarter to a record $65.62 per sq. ft. in the first.
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
222 West State Street
Suite 302
Trenton, NJ 08608
732-729-9619